cannabinoid Archives | Page 2 of 2

Home / Posts tagged cannabinoid (Page 2)

Radient Technologies Inc. Reports Record Revenue and Record Gross Profit for the Third Quarter of Fiscal 2020

EDMONTON, Alberta, Feb. 28 (Korea Bizwire) – Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to report its financial results for the third quarter of its fiscal year 2020, ended December 31, 2019. The financial statements and Management’s Discussion [...]

Radient Technologies Inc. Signs Supply Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc., for the Formulation and Manufacturing of Exclusive Branded Cannabis Products

EDMONTON, Alberta, Feb. 11 (Korea Bizwire) – Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce it has entered into a supply agreement (the “Agreement”) with Medical Cannabis by Shoppers, the online medical cannabis platform of leading Canadian pharmacy [...]

Radient Technologies Inc. Announces up to CAD $15.4 Million in Debenture Financings and Provides Corporate Update

EDMONTON, Alberta, Feb. 10 (Korea Bizwire) – Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce a total financing package of up to CAD $15,400,000 through the issuance of up to $10.4 million of unsecured convertible notes (the [...]

Radient Technologies Inc. Announces Changes to its Board of Directors

EDMONTON, Alberta, Feb. 7 (Korea Bizwire) – Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, announces the following changes to its Board of Directors, effective today. Addition of two Board Members: Radient is pleased to announce that Health Canada has approved [...]

Radient Technologies Inc. Signs Binding Letter of Intent to Enter into Sale-Leaseback Financing Agreement and Reaffirms Revenue Guidance of at Least $10 Million for Fiscal Q3 2020

EDMONTON, Alberta, Jan. 14 (Korea Bizwire) – Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce it has entered into a binding Letter of Intent (the “LOI”) for a Sale-Leaseback transaction in which 2238501 Alberta Ltd. (the “Purchaser”) [...]

Thar Process, Inc. and 51st Parallel Inc. Announce the Creation of Canada’s Largest Cannabinoid-Based Toll Processor: Thar Extracts Alberta ULC

CALGARY, Alberta, Dec. 17 (Korea Bizwire) — Thar Process, Inc. (“Thar”) and 51st Parallel Inc. (“51st”) are pleased to announce the creation of Canada’s first industrial-scale extraction and purification toll-processor, Thar Extracts Alberta ULC (the “Joint Venture” or “Thar Extracts Alberta”), owned 60% by Thar and 40% by 51st. Thar currently operates three industrial-scale extraction [...]

Radient Technologies Inc. Announces AGM Results

EDMONTON, Alberta, Oct. 28 (Korea Bizwire) – Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid based ingredients, formulations and products, today announces that all resolutions were passed by the requisite majority at its annual general meeting (“AGM”) held in Edmonton, Alberta, on October 25, 2019. [...]